BIRC5 and neoplasm: CRAd-S-pk7 infects cells by binding to anionic cell surface proteins through seven lysine residues (pk7) on the adenoviral fiber and subsequently initiating replication by way of E1 gene expression under the control of the tumor-specific promoter, survivin [4, 16].